
Reckitt Benckiser Group plc
RBGPF
Updated: 05/11/2026, 03:30:58
No historical data available
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
No summaries found.
- Share price
- $76.20
- Market cap
- $48.26B
- Exchange
- OTC
- Currency
- USD
- CEO
- Kris Licht
- Employees
- 36,200
- IPO date
- 07/11/2007
- Beta
- 0.255
- Last dividend
- $0.00
- Day range
- $74.40 – $76.20
- 52-week range
- $58.67 – $90.71
- 1-day performance
- 8.10%
- 1-year performance
- 29.88%
- Current drawdown (1Y)
- -16.00%
- CIK
- 0001420798
- CUSIP
- N/A
- ISIN
- GB00BSZBP530
- Created
- 07/12/2025, 13:55:48
- Last update
- 05/11/2026, 03:30:58
Track Reckitt Benckiser Group plc with an AI analyst
See which prediction-market events move RBGPF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.